The PHLS Response to a Pandemic of Influenza: An Action Plan
This document sets out the Public Health Laboratory Service (PHLS) action plan for responding to an influenza pandemic. The plan entails, in phase 0, interpandemic surveillance by the Communicable Disease Surveillance Centre (CDSC) and the Enteric & Respiratory Virus Laboratory (ERVL) of the Central Public Health Laboratory (CPHL), as well as maintenance by Area & Regional (A & R) Public Health Laboratories of updated diagnostic techniques for influenza. In phase 1 (the emergence of a 'shifted' influenza virus strain) a Pandemic Working Group will be convened to consider what action by PHLS is necessary. In phase 2 (pandemic influenza outside UK) the pre-defined roles for PHLS laboratories and CDSC will be adopted. When a pandemic is imminent in the United Kingdom (phase 3) the Working Group will coordinate PHLS activities and the Director of the Service will assess what special studies should be implemented. In phase 4, when the pandemic has reached the UK, the action plan sets out comprehensive measures that will be taken by CDSC, ERVL and A & R Laboratories to gather and collate information, provide DoH with weekly surveillance data and develop recommendations for prophylaxis, clinical management and treatment. When influenza activity has returned to background levels (phase 5) a report will be drafted by the Working Group prior to it being stood down by the Director of the Service. The response is summarised in tabular form in Table 1..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
1994 |
|---|---|
| Erschienen: |
1994 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Morgan-Capner, P. [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Behavioral sciences |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
JST032112785 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | JST032112785 | ||
| 003 | DE-627 | ||
| 005 | 20240117213606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150324s1994 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)JST032112785 | ||
| 035 | |a (JST)3520990 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Morgan-Capner, P. |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The PHLS Response to a Pandemic of Influenza: An Action Plan |
| 264 | 1 | |c 1994 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a This document sets out the Public Health Laboratory Service (PHLS) action plan for responding to an influenza pandemic. The plan entails, in phase 0, interpandemic surveillance by the Communicable Disease Surveillance Centre (CDSC) and the Enteric & Respiratory Virus Laboratory (ERVL) of the Central Public Health Laboratory (CPHL), as well as maintenance by Area & Regional (A & R) Public Health Laboratories of updated diagnostic techniques for influenza. In phase 1 (the emergence of a 'shifted' influenza virus strain) a Pandemic Working Group will be convened to consider what action by PHLS is necessary. In phase 2 (pandemic influenza outside UK) the pre-defined roles for PHLS laboratories and CDSC will be adopted. When a pandemic is imminent in the United Kingdom (phase 3) the Working Group will coordinate PHLS activities and the Director of the Service will assess what special studies should be implemented. In phase 4, when the pandemic has reached the UK, the action plan sets out comprehensive measures that will be taken by CDSC, ERVL and A & R Laboratories to gather and collate information, provide DoH with weekly surveillance data and develop recommendations for prophylaxis, clinical management and treatment. When influenza activity has returned to background levels (phase 5) a report will be drafted by the Working Group prior to it being stood down by the Director of the Service. The response is summarised in tabular form in Table 1. | ||
| 540 | |a Copyright 1994 Kluwer Academic Publishers | ||
| 650 | 4 | |a Influenza virus | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a Public Health Laboratories | |
| 650 | 4 | |a Health sciences |x Health and wellness |x Public health |x Epidemiology |x Disease outbreaks |x Epidemics |x Pandemics | |
| 650 | 4 | |a Biological sciences |x Biology |x Microbiology |x Microorganisms |x Viruses | |
| 650 | 4 | |a Political science |x Government |x Government agencies |x Intelligence services |x Surveillance | |
| 650 | 4 | |a Biological sciences |x Biology |x Microbiology |x Microorganisms |x Viruses |x RNA viruses |x Orthomyxoviridae | |
| 650 | 4 | |a Health sciences |x Medical conditions |x Diseases | |
| 650 | 4 | |a Health sciences |x Health and wellness |x Public health | |
| 650 | 4 | |a Health sciences |x Health and wellness |x Public health |x Epidemiology |x Disease incidence rates |x Morbidity | |
| 650 | 4 | |a Health sciences |x Medical conditions |x Infections | |
| 650 | 4 | |a Health sciences |x Medical conditions |x Diseases |x Infectious diseases | |
| 650 | 4 | |a Behavioral sciences |x Sociology |x Human societies |x Social groups |x Committees |x Subcommittees |x Proceedings 7th European Meeting of Influenza and Its Prevention | |
| 655 | 4 | |a research-article | |
| 773 | 1 | 8 | |g volume:10 |g year:1994 |g number:4 |g pages:497-502 |
| 856 | 4 | 0 | |u https://www.jstor.org/stable/3520990 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_JST | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 1994 |e 4 |h 497-502 | ||